Guangyu Shan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Guangyu Shan has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Yiming Lu
3 shared publications- Chenggang Zhang
School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China
2 shared publications Lei Li
Beijing Novogene Bioinformatics Technology Co., Ltd, Beijing 100015, P.R. China
2 shared publicationsWubin Qu
2 shared publicationsB. Liu
1 shared publicationBo Min
1 shared publication
Latest Publications
- Open Access
- 5 June 2020
- Published by Spandidos Publications in Oncology Letters
- Vol. 20 (2) , 1982-1988
A robust method for the rapid detection of microsatellite instability in colorectal cancer
Although several computational tools using next‑generation sequencing (NGS) data have been proposed to detect microsatellite instability (MSI) status, they still have limitations and need improvement. We developed a NovoPM‑MSI method to detect MSI status based on NGS data. This method evaluated target mononucleotide microsatellite loci that were sequenced during targeted gene enrichment analysis and reported sample instability score as the fraction of unstable loci within the target set after assessing locus instability by comparing length distribution in paired tumor‑normal samples. We validated this method against the conventional MSI‑PCR method in 113 paired colorectal cancer (CRC) specimens and compared the performance of NovoPM‑MSI to that of mSINGS and MANTIS in accuracy and runtime efficiency. By using the MSI status from MSI‑PCR as the gold standard, the three computational methods showed the same sensitivity of 88.9% but different specificities (NovoPM‑MSI 97.1%, MANTIS 86.5% and mSINGS 99.0%). Only NovoPM‑MSI could greatly improve both the sensitivity and specificity by setting an ambiguous interval. MANTIS had the shortest average runtime (16.3 sec), followed by NovoPM‑MSI (18.3 sec) and mSINGS (109.0 sec). In short, the NovoPM‑MSI method provides a fast and reliable MSI detection method with accuracy comparable to MSI‑PCR in paired CRC samples.
- 5 June 2020
- Published by Spandidos Publications in Oncology Letters
- Vol. 20 (2) , 1982-1988
Open AccessA robust method for the rapid detection of microsatellite instability in colorectal cancer
Although several computational tools using next‑generation sequencing (NGS) data have been proposed to detect microsatellite instability (MSI) status, they still have limitations and need improvement. We developed a NovoPM‑MSI method to detect MSI status based on NGS data. This method evaluated target mononucleotide microsatellite loci that were sequenced during targeted gene enrichment analysis and reported sample instability score as the fraction of unstable loci within the target set after assessing locus instability by comparing length distribution in paired tumor‑normal samples. We validated this method against the conventional MSI‑PCR method in 113 paired colorectal cancer (CRC) specimens and compared the performance of NovoPM‑MSI to that of mSINGS and MANTIS in accuracy and runtime efficiency. By using the MSI status from MSI‑PCR as the gold standard, the three computational methods showed the same sensitivity of 88.9% but different specificities (NovoPM‑MSI 97.1%, MANTIS 86.5% and mSINGS 99.0%). Only NovoPM‑MSI could greatly improve both the sensitivity and specificity by setting an ambiguous interval. MANTIS had the shortest average runtime (16.3 sec), followed by NovoPM‑MSI (18.3 sec) and mSINGS (109.0 sec). In short, the NovoPM‑MSI method provides a fast and reliable MSI detection method with accuracy comparable to MSI‑PCR in paired CRC samples.
- Open Access
- 28 May 2020
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 18 (1) , 1-9
A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients
Background: With the recent emergence of immune checkpoint inhibitors, microsatellite instability (MSI) status has become an important biomarker for immune checkpoint blockade therapy. There are growing technical demands for the integration of different genomic alterations profiling including MSI analysis in a single assay for full use of the limited tissues. Methods: Tumor and paired control samples from 64 patients with primary colorectal cancer were enrolled in this study, including 14 MSI-high (MSI-H) cases and 50 microsatellite stable (MSS) cases determined by MSI-PCR. All the samples were sequenced by a customized NGS panel covering 2.2 MB. A training dataset of 28 samples was used for selection of microsatellite loci and a novel NGS-based MSI status classifier, USCI-msi, was developed. NGS-based MSI status, single nucleotide variant (SNV) and tumor mutation burden (TMB) were detected for all patients. Most of the patients were also independently detected by immunohistochemistry (IHC) staining. Results: A 9-loci model for detecting microsatellite instability was able to correctly predict MSI status with 100% sensitivity and specificity compared with MSI-PCR, and 84.3% overall concordance with IHC staining. Mutations in cancer driver genes (APC, TP53, and KRAS) were dispersed in MSI-H and MSS cases, while BRAF p.V600E and frameshifts in TCF7L2 gene occurred only in MSI-H cases. Mismatch repair (MMR)-related genes are highly mutated in MSI-H samples. Conclusion: We established a new NGS-based MSI classifier, USCI-msi, with as few as 9 microsatellite loci for detecting MSI status in CRC cases. This approach possesses 100% sensitivity and specificity, and performed robustly in samples with low tumor purity.
- 28 May 2020
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 18 (1) , 1-9
Open AccessA novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients
Background: With the recent emergence of immune checkpoint inhibitors, microsatellite instability (MSI) status has become an important biomarker for immune checkpoint blockade therapy. There are growing technical demands for the integration of different genomic alterations profiling including MSI analysis in a single assay for full use of the limited tissues. Methods: Tumor and paired control samples from 64 patients with primary colorectal cancer were enrolled in this study, including 14 MSI-high (MSI-H) cases and 50 microsatellite stable (MSS) cases determined by MSI-PCR. All the samples were sequenced by a customized NGS panel covering 2.2 MB. A training dataset of 28 samples was used for selection of microsatellite loci and a novel NGS-based MSI status classifier, USCI-msi, was developed. NGS-based MSI status, single nucleotide variant (SNV) and tumor mutation burden (TMB) were detected for all patients. Most of the patients were also independently detected by immunohistochemistry (IHC) staining. Results: A 9-loci model for detecting microsatellite instability was able to correctly predict MSI status with 100% sensitivity and specificity compared with MSI-PCR, and 84.3% overall concordance with IHC staining. Mutations in cancer driver genes (APC, TP53, and KRAS) were dispersed in MSI-H and MSS cases, while BRAF p.V600E and frameshifts in TCF7L2 gene occurred only in MSI-H cases. Mismatch repair (MMR)-related genes are highly mutated in MSI-H samples. Conclusion: We established a new NGS-based MSI classifier, USCI-msi, with as few as 9 microsatellite loci for detecting MSI status in CRC cases. This approach possesses 100% sensitivity and specificity, and performed robustly in samples with low tumor purity.
- 28 November 2019
- Published by Wiley in Human Mutation
- Vol. 41 (3) , 696-708
Comprehensive profiling of BRCA1 and BRCA2 variants in breast and ovarian cancer in Chinese patients
The identification and interpretation of germline BRCA1/2 variants becomes increasingly important in breast and ovarian cancer treatment. However, there is no comprehensive analysis of the germline BRCA1/2 variants in Chinese population. Here we performed a systematic review and meta‐analysis on such variants from 94 publications. A total of 2128 BRCA1/2 variant records were extracted, including 601 from BRCA1 and 632 from BRCA2. 414, 734, 449, 307 were also recorded in the BIC, ClinVar, ENIGMA and UMD databases, respectively, and 579 variants were newly reported. Subsequent analysis showed that the overall germline BRCA1/2 pathogenic variant frequency was 5.7% and 21.8% in Chinese breast and ovarian cancer, respectively. Populations with high‐risk factors exhibited higher pathogenic variant percentage. Furthermore, the variant profile in Chinese is distinctive from that in other ethnic groups with no distinct founder pathogenic variants. We also tested our in‐house ACMG‐guided pathogenicity interpretation procedure for Chinese BRCA1/2 variants. Our results achieved a consistency of 91.2%‐97.6% (5‐grade classification) or 98.4%‐100% (2‐grade classification) with public databases. In conclusion, this study represents the first comprehensive meta‐analysis of Chinese BRCA1/2 variants and validates our in‐house pathogenicity interpretation procedure, thereby providing guidance for further PARP inhibitor development and companion diagnostics in Chinese population.
- 28 November 2019
- Published by Wiley in Human Mutation
- Vol. 41 (3) , 696-708
Comprehensive profiling of BRCA1 and BRCA2 variants in breast and ovarian cancer in Chinese patients
The identification and interpretation of germline BRCA1/2 variants becomes increasingly important in breast and ovarian cancer treatment. However, there is no comprehensive analysis of the germline BRCA1/2 variants in Chinese population. Here we performed a systematic review and meta‐analysis on such variants from 94 publications. A total of 2128 BRCA1/2 variant records were extracted, including 601 from BRCA1 and 632 from BRCA2. 414, 734, 449, 307 were also recorded in the BIC, ClinVar, ENIGMA and UMD databases, respectively, and 579 variants were newly reported. Subsequent analysis showed that the overall germline BRCA1/2 pathogenic variant frequency was 5.7% and 21.8% in Chinese breast and ovarian cancer, respectively. Populations with high‐risk factors exhibited higher pathogenic variant percentage. Furthermore, the variant profile in Chinese is distinctive from that in other ethnic groups with no distinct founder pathogenic variants. We also tested our in‐house ACMG‐guided pathogenicity interpretation procedure for Chinese BRCA1/2 variants. Our results achieved a consistency of 91.2%‐97.6% (5‐grade classification) or 98.4%‐100% (2‐grade classification) with public databases. In conclusion, this study represents the first comprehensive meta‐analysis of Chinese BRCA1/2 variants and validates our in‐house pathogenicity interpretation procedure, thereby providing guidance for further PARP inhibitor development and companion diagnostics in Chinese population.
- 1 November 2017
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 12 (11) , S2385
PUB060 Comparison of Tumor Mutational Burden (TMB) Derived from Whole Exome and Large Panel Sequencing in Lung Cancer
- 1 November 2017
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 12 (11) , S2385
PUB060 Comparison of Tumor Mutational Burden (TMB) Derived from Whole Exome and Large Panel Sequencing in Lung Cancer
- Open Access
- 1 December 2016
- Published by Wolters Kluwer Health in Medicine
- Vol. 95 (49) , e5585
A MeSH-based text mining method for identifying novel prebiotics
Prebiotics contribute to the well-being of their host by altering the composition of the gut microbiota. Discovering new prebiotics is a challenging and arduous task due to strict inclusion criteria; thus, highly limited numbers of prebiotic candidates have been identified. Notably, the large numbers of published studies may contain substantial information attached to various features of known prebiotics that can be used to predict new candidates. In this paper, we propose a medical subject headings (MeSH)-based text mining method for identifying new prebiotics with structured texts obtained from PubMed. We defined an optimal feature set for prebiotics prediction using a systematic feature-ranking algorithm with which a variety of carbohydrates can be accurately classified into different clusters in accordance with their chemical and biological attributes. The optimal feature set was used to separate positive prebiotics from other carbohydrates, and a cross-validation procedure was employed to assess the prediction accuracy of the model. Our method achieved a specificity of 0.876 and a sensitivity of 0.838. Finally, we identified a high-confidence list of candidates of prebiotics that are strongly supported by the literature. Our study demonstrates that text mining from high-volume biomedical literature is a promising approach in searching for new prebiotics.
- 1 December 2016
- Published by Wolters Kluwer Health in Medicine
- Vol. 95 (49) , e5585
Open AccessA MeSH-based text mining method for identifying novel prebiotics
Prebiotics contribute to the well-being of their host by altering the composition of the gut microbiota. Discovering new prebiotics is a challenging and arduous task due to strict inclusion criteria; thus, highly limited numbers of prebiotic candidates have been identified. Notably, the large numbers of published studies may contain substantial information attached to various features of known prebiotics that can be used to predict new candidates. In this paper, we propose a medical subject headings (MeSH)-based text mining method for identifying new prebiotics with structured texts obtained from PubMed. We defined an optimal feature set for prebiotics prediction using a systematic feature-ranking algorithm with which a variety of carbohydrates can be accurately classified into different clusters in accordance with their chemical and biological attributes. The optimal feature set was used to separate positive prebiotics from other carbohydrates, and a cross-validation procedure was employed to assess the prediction accuracy of the model. Our method achieved a specificity of 0.876 and a sensitivity of 0.838. Finally, we identified a high-confidence list of candidates of prebiotics that are strongly supported by the literature. Our study demonstrates that text mining from high-volume biomedical literature is a promising approach in searching for new prebiotics.
- Open Access
- 11 April 2016
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 44 (13) , 6200-6212
Defining the multivalent functions of CTCF from chromatin state and three-dimensional chromatin interactions
CCCTC-binding factor (CTCF) is a multi-functional protein that is assigned various, even contradictory roles in the genome. High-throughput sequencing-based technologies such as ChIP-seq and Hi-C provided us the opportunity to assess the multivalent functions of CTCF in the human genome. The location of CTCF-binding sites with respect to genomic features provides insights into the possible roles of this protein. Here we present the first genome-wide survey and characterization of three important functions of CTCF: enhancer insulator, chromatin barrier and enhancer linker. We developed a novel computational framework to discover the multivalent functions of CTCF based on chromatin state and three-dimensional chromatin architecture. We applied our method to five human cell lines and identified ∼46 000 non-redundant CTCF sites related to the three functions. Disparate effects of these functions on gene expression were found and distinct genomic features of these CTCF sites were characterized in GM12878 cells. Finally, we investigated the cell-type specificities of CTCF sites related to these functions across five cell types. Our study provides new insights into the multivalent functions of CTCF in the human genome.
- 11 April 2016
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 44 (13) , 6200-6212
Open AccessDefining the multivalent functions of CTCF from chromatin state and three-dimensional chromatin interactions
CCCTC-binding factor (CTCF) is a multi-functional protein that is assigned various, even contradictory roles in the genome. High-throughput sequencing-based technologies such as ChIP-seq and Hi-C provided us the opportunity to assess the multivalent functions of CTCF in the human genome. The location of CTCF-binding sites with respect to genomic features provides insights into the possible roles of this protein. Here we present the first genome-wide survey and characterization of three important functions of CTCF: enhancer insulator, chromatin barrier and enhancer linker. We developed a novel computational framework to discover the multivalent functions of CTCF based on chromatin state and three-dimensional chromatin architecture. We applied our method to five human cell lines and identified ∼46 000 non-redundant CTCF sites related to the three functions. Disparate effects of these functions on gene expression were found and distinct genomic features of these CTCF sites were characterized in GM12878 cells. Finally, we investigated the cell-type specificities of CTCF sites related to these functions across five cell types. Our study provides new insights into the multivalent functions of CTCF in the human genome.
- Open Access
- 19 June 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (6) , e0130622
DELTA: A Distal Enhancer Locating Tool Based on AdaBoost Algorithm and Shape Features of Chromatin Modifications
Accurate identification of DNA regulatory elements becomes an urgent need in the post-genomic era. Recent genome-wide chromatin states mapping efforts revealed that DNA elements are associated with characteristic chromatin modification signatures, based on which several approaches have been developed to predict transcriptional enhancers. However, their practical application is limited by incomplete extraction of chromatin features and model inconsistency for predicting enhancers across different cell types. To address these issues, we define a set of non-redundant shape features of histone modifications, which shows high consistency across cell types and can greatly reduce the dimensionality of feature vectors. Integrating shape features with a machine-learning algorithm AdaBoost, we developed an enhancer predicting method, DELTA (Distal Enhancer Locating Tool based on AdaBoost). We show that DELTA significantly outperforms current enhancer prediction methods in prediction accuracy on different datasets and can predict enhancers in one cell type using models trained in other cell types without loss of accuracy. Overall, our study presents a novel framework for accurately identifying enhancers from epigenetic data across multiple cell types.
- 19 June 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (6) , e0130622
Open AccessDELTA: A Distal Enhancer Locating Tool Based on AdaBoost Algorithm and Shape Features of Chromatin Modifications
Accurate identification of DNA regulatory elements becomes an urgent need in the post-genomic era. Recent genome-wide chromatin states mapping efforts revealed that DNA elements are associated with characteristic chromatin modification signatures, based on which several approaches have been developed to predict transcriptional enhancers. However, their practical application is limited by incomplete extraction of chromatin features and model inconsistency for predicting enhancers across different cell types. To address these issues, we define a set of non-redundant shape features of histone modifications, which shows high consistency across cell types and can greatly reduce the dimensionality of feature vectors. Integrating shape features with a machine-learning algorithm AdaBoost, we developed an enhancer predicting method, DELTA (Distal Enhancer Locating Tool based on AdaBoost). We show that DELTA significantly outperforms current enhancer prediction methods in prediction accuracy on different datasets and can predict enhancers in one cell type using models trained in other cell types without loss of accuracy. Overall, our study presents a novel framework for accurately identifying enhancers from epigenetic data across multiple cell types.